A first-in-man phase I tolerability and pharmacokinetic study of the cyclin-dependent kinase-inhibitor AZD5438 in healthy male volunteers

✍ Scribed by D. Ross Camidge; Dominic Smethurst; Jim Growcott; Nigel C. Barrass; John R. Foster; Salvatore Febbraro; Helen Swaisland; Andrew Hughes

• Publisher: Springer
• Year: 2006
• Tongue: English
• Weight: 324 KB
• Volume: 60
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s00280-006-0371-x